Global Healthcare Analyst

Tina Banerjee

Equity research analyst having 15+ years of experience, with an interest on fundamentally strong global healthcare companies. I have been helping investors to find future winners in healthcare space to grow their wealth by focusing on the strength and potential of the business models of the companies. My initiating coverage reports and pitch help investors to know ‘what to buy’, ‘why to buy’, and ‘when to buy’. My clients always remain on top of the sector with the help of my timely and detailed notes on earnings or any news update. I also provide broader view on the entire healthcare sector through periodic thematic reports.

Equity Capital Markets

Liuliu Orchard Group / Equity Capital Markets

<ul>
<li>Liuliumei Co launched its Hongkong IPO aiming to raise up to HK$ 499.2M. It is a fruit snack company focusing on the plum-based products.</li>
<li>The company intends to use the proceeds for expansion of production capacity, enhance brand recognition &amp; sales network, advance R&amp;D and for working capital etc.</li>
<li>The growth outlook justifies the valuation. We would recommend the investors to subscribe to the issue and cash in on the secular growth story the company is offering.</li>
</ul>


Liuliumei Co launched its Hongkong IPO aiming to raise up to HK$ 499.2M. It is a fruit snack company focusing on the plum-based products.
The company intends to use the proceeds for expansion of production capacity, enhance brand recognition &amp; sales network, advance R&amp;D and for working capital etc.
The growth outlook justifies the valuation. We would recommend the investors to subscribe to the issue and cash in on the secular growth story the company is offering.


Liuliumei Co IPO: Product Diversification, Margin & Volume Strength Make It A Plum Buy